Cargando…
Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
Gut microbiota dysbiosis plays an important role in the progression of non-alcoholic fatty liver disease (NAFLD), and no approved drugs are available for NAFLD treatment. In this study, we aimed to explore the dynamic changes of gut microbiota at the different stages of NAFLD and determine whether u...
Autores principales: | Li, Hu, Wang, Qingling, Chen, Peizhan, Zhou, Chenghua, Zhang, Xinxin, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685972/ https://www.ncbi.nlm.nih.gov/pubmed/34938193 http://dx.doi.org/10.3389/fphar.2021.788558 |
Ejemplares similares
-
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022) -
Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021) -
Vitamin C and vitamin D(3) alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis
por: Chen, Qingling, et al.
Publicado: (2023) -
Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice
por: Hu, Qiuyue, et al.
Publicado: (2022) -
Steatohepatitic Variant of Hepatocellular Carcinoma: A Focused Review
por: Olofson, Andrea Morgan, et al.
Publicado: (2018)